187 related articles for article (PubMed ID: 26522589)
1. Bub1 is required for maintaining cancer stem cells in breast cancer cell lines.
Han JY; Han YK; Park GY; Kim SD; Lee CG
Sci Rep; 2015 Nov; 5():15993. PubMed ID: 26522589
[TBL] [Abstract][Full Text] [Related]
2. Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis.
Wang Z; Katsaros D; Shen Y; Fu Y; Canuto EM; Benedetto C; Lu L; Chu WM; Risch HA; Yu H
PLoS One; 2015; 10(8):e0136246. PubMed ID: 26287798
[TBL] [Abstract][Full Text] [Related]
3. The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling.
Nyati S; Schinske-Sebolt K; Pitchiaya S; Chekhovskiy K; Chator A; Chaudhry N; Dosch J; Van Dort ME; Varambally S; Kumar-Sinha C; Nyati MK; Ray D; Walter NG; Yu H; Ross BD; Rehemtulla A
Sci Signal; 2015 Jan; 8(358):ra1. PubMed ID: 25564677
[TBL] [Abstract][Full Text] [Related]
4. BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer.
Wang S; Liu X; Yang M; Yuan D; Ye K; Qu X; Wang X
Dis Markers; 2022; 2022():2760432. PubMed ID: 35493295
[TBL] [Abstract][Full Text] [Related]
5. BUB1 immunolocalization in breast carcinoma: its nuclear localization as a potent prognostic factor of the patients.
Takagi K; Miki Y; Shibahara Y; Nakamura Y; Ebata A; Watanabe M; Ishida T; Sasano H; Suzuki T
Horm Cancer; 2013 Apr; 4(2):92-102. PubMed ID: 23288590
[TBL] [Abstract][Full Text] [Related]
6. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
[TBL] [Abstract][Full Text] [Related]
7. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
Mao J; Song B; Shi Y; Wang B; Fan S; Yu X; Tang J; Li L
Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524
[TBL] [Abstract][Full Text] [Related]
8. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of the anti-tumor activity of Methyl 2-(-5-fluoro-2-hydroxyphenyl)-1 H-benzo[d]imidazole-5-carboxylate against breast cancer in vitro and in vivo.
Hasanpourghadi M; Pandurangan AK; Karthikeyan C; Trivedi P; Mustafa MR
Oncotarget; 2017 Apr; 8(17):28840-28853. PubMed ID: 28392503
[TBL] [Abstract][Full Text] [Related]
10. Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and BAY-524.
Baron AP; von Schubert C; Cubizolles F; Siemeister G; Hitchcock M; Mengel A; Schröder J; Fernández-Montalván A; von Nussbaum F; Mumberg D; Nigg EA
Elife; 2016 Feb; 5():. PubMed ID: 26885717
[TBL] [Abstract][Full Text] [Related]
11. Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK/ERK-dependent signaling pathway.
Ahn HJ; Kim G; Park KS
Biochem Biophys Res Commun; 2013 Aug; 437(4):557-64. PubMed ID: 23850691
[TBL] [Abstract][Full Text] [Related]
12. MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.
Jiang J; Li Z; Yu C; Chen M; Tian S; Sun C
Cancer Lett; 2015 Jan; 356(2 Pt B):962-70. PubMed ID: 25444909
[TBL] [Abstract][Full Text] [Related]
13. Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells.
Cappello P; Blaser H; Gorrini C; Lin DC; Elia AJ; Wakeham A; Haider S; Boutros PC; Mason JM; Miller NA; Youngson B; Done SJ; Mak TW
Oncogene; 2014 May; 33(18):2375-84. PubMed ID: 23708664
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
[TBL] [Abstract][Full Text] [Related]
15. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
[TBL] [Abstract][Full Text] [Related]
16. MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence.
Xia H; Kong SN; Chen J; Shi M; Sekar K; Seshachalam VP; Rajasekaran M; Goh BKP; Ooi LL; Hui KM
Cancer Lett; 2016 Dec; 383(1):85-93. PubMed ID: 27693640
[TBL] [Abstract][Full Text] [Related]
17. Possible causes of chromosome instability: comparison of chromosomal abnormalities in cancer cell lines with mutations in BRCA1, BRCA2, CHK2 and BUB1.
Grigorova M; Staines JM; Ozdag H; Caldas C; Edwards PA
Cytogenet Genome Res; 2004; 104(1-4):333-40. PubMed ID: 15162061
[TBL] [Abstract][Full Text] [Related]
18. Targeted Therapy for Breast Cancer Stem Cells by Liposomal Delivery of siRNA against Fibronectin EDB.
Sun Y; Kim HS; Saw PE; Jon S; Moon WK
Adv Healthc Mater; 2015 Aug; 4(11):1675-80. PubMed ID: 26097122
[TBL] [Abstract][Full Text] [Related]
19. NF-κB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype.
Yamamoto M; Taguchi Y; Ito-Kureha T; Semba K; Yamaguchi N; Inoue J
Nat Commun; 2013; 4():2299. PubMed ID: 23934482
[TBL] [Abstract][Full Text] [Related]
20. Bub1 up-regulation and hyperphosphorylation promote malignant transformation in SV40 tag-induced transgenic mouse models.
Guo C; Wu G; Chin JL; Bauman G; Moussa M; Wang F; Greenberg NM; Taylor SS; Xuan JW
Mol Cancer Res; 2006 Dec; 4(12):957-69. PubMed ID: 17189386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
